Leonetti, Alessandro
Sharma, Sugandhi
Minari, Roberta
Perego, Paola
Giovannetti, Elisa
Tiseo, Marcello http://orcid.org/0000-0002-9204-1728
Funding for this research was provided by:
Fondazione Cariplo (2016-1019)
Italian Association for Cancer Research, AIRC/Start-Up grant, and Fondazione Pisana per la Scienza
Associazione Italiana per la Ricerca sul Cancro (IG2017-20074)
Article History
Received: 5 March 2019
Revised: 9 August 2019
Accepted: 23 August 2019
First Online: 30 September 2019
Competing interests
: M.T.: advisory boards and speakers’ fee for Astra-Zeneca. The remaining authors declare no competing interests.
: Not applicable.
: Grant by AIRC (Italian Association for Cancer Research) to M.T. (grant IG2017-20074), grant by Fondazione CARIPLO-Regione Lombardia to P.P. (grant 2016-1019), grants by Italian Association for Cancer Research, AIRC/Start-Up grant, and by Fondazione Pisana per la Scienza, to E.G.
: Not applicable.
: Not applicable.